Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoking cessation with smokeless tobacco buccal tablets vs nicotine replacement therapy
2005-004626-10Phase 2Completed
- Sponsor
- Gentofte Hospital
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of nicotine in nicotine dependence (3 arms), sponsored by Gentofte Hospital. Primary endpoints: Quit rate (point prevalence at 6 months), Sustained quit rate from week 4 to 6 months and 1 more. Started Jan 2006; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2005-004626-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004626-10.